SMISS Asia Pacific 2024 Congress and training program
26 Junio 2024 - 11:00AM
SMISS Asia Pacific 2024 Congress and training program
Press
release Ecully,
June 26, 2024 – 6 p.m.
Hands-on surgical training in Hong
Kongat the SMISS Asia Pacific 2024
Congress
The Spineway Group, a specialist in innovative
implants for the treatment of severe spine disorders, participated
in the 4th SMISS Asia Pacific congress, dedicated to minimally
invasive surgery, held in Hong Kong on June 13 and 14. Spineway was
a Bronze Sponsor of the event, where the Group presented its ESP
(cervical and lumbar) prostheses through demonstrations and
scientific papers, highlighting the growing interest in cervical
and lumbar prostheses in this historic region for the Group.This
annual congress attracts surgeons from many Asian countries and has
allowed Spineway to consolidate its presence, particularly in Hong
Kong, where it has been marketing ESP disc prostheses for over
seven years.
As an extension of this event and in addition to
the scientific presentations, SMISS, in collaboration with the CUHK
(Chinese University of Hong Kong), organized hands-on training
sessions at the Orthopaedic Learning Centre anatomy laboratory of
the Prince of Wales Hospital on June 16-24. During these practical
training sessions, Spineway organized two workshops dedicated to
training surgeons in total disc replacement, one with its cervical
prostheses (CP-ESP), led by Dr. Philip Cheung (Matilda
International Hospital), and the other with its lumbar prostheses
(LP-ESP), led by Dr. Raymond Yip (Matilda International
Hospital).
These courses, which are very popular with
surgeons, allow professionals to perform surgeries to discover or
perfect surgical techniques. This hands-on workshop was held in
Hong Kong and was attended by approximately 20 Asian surgeons. It
was also streamed over the Internet, subject to payment of a
registration fee.
Spineway is continuing its sales and
marketing initiatives to raise its profile among spine surgeons in
high-potential areas. Its presence at a congress dedicated to
minimally invasive surgery confirms the Group’s aim of becoming a
major player in less invasive spine treatments.
Next
event:July 15, 2024 –
H1 2024 revenue
SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY
SAVINGS PLANS FOR SMES)Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
independent distributors and derives more than 70% of its revenue
from exports.ISIN: FR001400BVK2 –
ALSPW
Contacts:
SPINEWAY GROUPShareholder-services lineAvailable
Tuesday through Thursday+33 (0)806 706 060 |
Eligible PEA / PMEALSPWEuronext Growth |
AELIUMFinance & CommunicationInvestor
relationsSolène Kennisspineway@aelium.fr |
- CPSPW-SMISS_Asia_Pacific_GB_DEF